PATENT CLAIM ANALYSIS

Application Number: 16288001
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["436", "150000"]

Abstract:
One embodiment of the present application sets forth a method for predicting recurrence of cancerous cells in a patient that includes measuring, by a first subset of electrodes included in an electrode array operating at a first frequency, a first impedance of a first section of a first sample of tissue excised from the patient, computing a first Cole relaxation frequency for the first section of the first sample based on the first impedance, and generating a first prediction relating to cancerous cells in the patient based at least in part on the first Cole relaxation frequency.

Claim (Index 13):
The apparatus of  claim 12 , further comprising:\n a second subset of electrodes included in the electrode array that measures, at the first frequency, a second impedance of a second section of the first sample; and a controller that:\n electrically connects, via the selector, the first subset of electrodes when measuring the first impedance, and \n electrically connects, via the selector, the second subset of electrodes when measuring the second impedance.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 2.0
- Patent Class: 436.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12042425', '10866913', '11096665', '12316032', '14269784']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6146130815613039
- 35 USC 102 Novelty (BERT): 0.4742359491068875
- Combined Prediction Score: 0.6005753683158622
- Mean Citation Score: 146.70876
- Max Citation Score: 148.75703
- Similarity Product: 94.3251598987174

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test